Lv1
30 积分 2023-10-31 加入
The efficacy and safety profile of third-line treatment in patients with metastatic pancreatic adenocarcinoma
11天前
已完结
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer
3个月前
已完结
Investigating the Pathogenicity of Uncommon KRAS Mutations and Their Association with Clinicopathologic Characteristics in Patients with Colorectal Cancer
3个月前
已完结
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer
4个月前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
5个月前
已完结
Profiling Interactions Between Bicyclol and SLC/ABC Transporters: Advancing Clinical Safety and Efficacy in Combination Therapy
5个月前
已完结
Integrated mutational landscape analysis of endometrial stromal sarcoma
5个月前
已完结
Real-World outcomes of Non-Small cell lung cancer patients harbouring KRAS G12C and KRAS G12D mutations
7个月前
已完结
Correlations of response rate and progression-free survival with overall survival in immunotherapy trials for metastatic non-small-cell lung cancer: an FDA pooled analysis
7个月前
已完结
基于倾向性评分匹配的肺腺癌二线化疗联合贝伐珠单抗或免疫检查点抑制剂的回顾性研究
7个月前
已完结
皖公网安备34019202002308
